Phaseline

Companies › Medicago

Medicago: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 2; Infectious disease.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
CoVLP adjuvanted with AS03
Recombinant coronavirus-like particle vaccine
–Phase 2SARS-CoV-2 Infection–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT04636697CoVLP adjuvanted with AS03Phase 2SARS-CoV-2 InfectionInfectious diseaseAug 2021

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

CastleVax Brii Biosciences Eveliqure Biotechnologies Sanaria SIGA Technologies

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.